Multidrug-resistant tuberculosis treatment with linezolid-containing regimen

Maham Farshidpour, Golnaz Ebrahimi, Mehdi Mirsaeidi

Research output: Contribution to journalArticle

3 Scopus citations


The following is a case of multidrug-resistant pulmonary tuberculosis (MDR-TB) that was treated successfully with a linezolid-containing regimen. It was found that linezolid is an efficient medicine for MDR-TB treatment with an acceptable side effect profile. Treatment was maintained for 18. months, and closely monitoring toxicities did not reveal evidence of any neurologic adverse effects. However, despite our expectation, thrombocytopenia was seen after 2. years follow-up.

Original languageEnglish (US)
Pages (from-to)233-236
Number of pages4
JournalInternational Journal of Mycobacteriology
Issue number4
StatePublished - Dec 2013


  • Linezolid
  • Multidrug-resistant tuberculosis
  • Thrombocytopenia
  • Treatment

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Multidrug-resistant tuberculosis treatment with linezolid-containing regimen'. Together they form a unique fingerprint.

  • Cite this